Sign up for our daily briefing

Make your busy days simpler with the Axios AM and PM newsletters. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to the Axios Closer newsletter for insights into the day’s business news and trends and why they matter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with the Axios Sports newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with the Axios Des Moines newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with the Axios Tampa Bay newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!
Data: Axios-Ipsos survey; Chart: Michelle McGhee/Axios

One month into his administration, President Biden has won the confidence of a majority of Americans in his ability to get Americans vaccinated and reopen the schools, according to the latest installment of the Axios/Ipsos Coronavirus Index.

The catch: That confidence will only last if Americans see a clear improvement in their lives and a path back to normal, or something close to it, in the coming months.

By the numbers: 63% of respondents in this week's poll said they're very or somewhat confident in the new administration's ability to make the vaccines widely available, with 36% saying they're not very confident or not confident at all.

  • 58% said they're confident that the administration can distribute the vaccines quickly, while 41% said they're not confident.
  • And 56% said they're confident in the administration's ability to get K-12 students back to school in person, while 43% say they're not confident.

Hyper-partisanship is driving these numbers.

  • Democrats are strongly confident in the Biden administration, while Republicans showed a lopsided lack of confidence and independents narrowly back the administration.
  • On schools, for example, Democrats have confidence in the Biden administration 81% to 18%, Republicans lack confidence 29% to 71%, and independents lean toward the administration 56% to 44%.

Since October, right before the election, public opinion has completely reversed itself on whether the federal government has gotten better or worse at handling the pandemic.

  • When we asked the question in late October, 26% of respondents said the federal government's handling had gotten better since the beginning of the pandemic, with 46% saying it had gotten worse.
  • In this week's poll, those results had flipped: 45% now say the federal government's handling of the pandemic has gotten better, with 26% saying it has gotten worse.

Between the lines: Biden has built much of his presidency on his promise to help get the pandemic under control, from his push for the $1.9 trillion COVID relief package to his bulk orders of extra doses of vaccines and his public vows to put scientists' recommendations front and center.

  • The promise of bringing competence and seriousness to the federal government's COVID response is "Biden's bailiwick," said Cliff Young, president of Ipsos U.S. Public Affairs.
  • That means he'll be judged on his results, Young said, and Americans will be looking for a real improvement in their lives in the coming months, from the safe reopening of schools to the ability to go to restaurants and other public places again.
  • "If this thing keeps stretching out ... that could erode fairly quickly his underlying support," Young said. "I think Americans will give him more than 100 days, but probably less than six months."

Of note: There's been a slight decline in the share of Americans who say they're worried about getting sick, from 74% two weeks ago to 69% now.

  • But at the same time, the share of Americans who are wearing two masks has inched up as public health experts have started to recommend it — from 15% in our poll at the end of January to 21% now.

Methodology: This Axios/Ipsos Poll was conducted Feb. 19-22 by Ipsos' KnowledgePanel®. This poll is based on a nationally representative probability sample of 1,029 general population adults age 18 or older.

  • The margin of sampling error is ±3.3 percentage points at the 95% confidence level, for results based on the entire sample of adults.

Go deeper

Biden on COVID deaths milestone: "We have to resist becoming numb"

President Biden, first lady Jill Biden, Vice President Kamala Harris and first gentleman Douglas Emhoff at the White House ceremony. Photo: Jim Lo Scalzo/EPA/Bloomberg via Getty Images

President Biden urged Americans to "remember those we lost and remember those we left behind" in a candle-lighting ceremony Monday — noting the "grim milestone" of the U.S. surpassing 500,000 COVID-19 deaths.

Details: "As a nation, we can't accept such a cruel fate. We have to resist becoming numb to the sorrow," the president said, calling on the U.S. to fight the coronavirus together.

Feb 22, 2021 - Health

FDA: Modified vaccines for COVID variants would not require large clinical trials

Photo: Michael Sohn/POOL/AFP via Getty Images

Developers for COVID-19 therapeutics, vaccines and testing do not need to conduct large and lengthy clinical trials to address new coronavirus variants, new guidance from the Food and Drug Administration said Monday.

Why it matters: Mutated versions of the coronavirus threaten to prolong the pandemic, possibly for years to come — especially if current treatments are rendered less effective. The FDA's updated recommendations could greatly accelerate the emergency authorization process to address these concerns.

Updated 14 hours ago - Politics & Policy

Omicron dashboard

Illustration: Brendan Lynch/Axios

  1. Health: Omicron pushes COVID deaths toward 2,000 per day — The pandemic-proof health care giant.
  2. Vaccines: No evidence that healthy children, teens need boosters, WHO says — Starbucks drops worker vaccine or test requirement after SCOTUS ruling — Kids' COVID vaccination rates are particularly low in rural America.
  3. Politics: Biden concedes U.S. should have done more testing — Arizona says it "will not be intimidated" by Biden on anti-mask school policies.
  4. World: American Airlines flight to London forced to turn around over mask dispute — WHO: COVID health emergency could end this year — Greece imposes vaccine mandate for people 60 and older.
  5. Variant tracker